Clinical Trial Update: Cardiac Autonomic Neuropathy in Patients With Metabolic Syndrome [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating cardiac autonomic neuropathy in patients with metabolic syndrome has completed; no detailed results are provided in the update.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Syndrome

Snippet

Sponsor: University of Michigan | Conditions: Metabolic Syndrome | Phase 1 | Status: COMPLETED